Total Funding
47
57
Total FundingPost-IPO Equity raised
Growth Score
-24 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
166868
Rafael Holdings is a company focused on the development of novel cancer therapies.
- Pat Fabbio: Chief Financial OfficerPast Role: Progenics Pharmaceuticals, CFO
Patrick Fabbio: CFO
About the Company
Rafael Holdings is a company focused on the development of novel cancer therapies. The company invests in novel cancer therapeutics that have the potential to improve and extend the lives of patients
